Awareness of Nucleic Acid-Based Therapies

In this Syndicated Report we had two goals:

  • Provide a baseline understanding of current knowledge among physicians regarding the types of nucleic acid-based therapies, their mechanisms of action, and their current and future promise.
  • Serve as a vehicle for future surveys to assess how knowledge and perceptions change over time.

Methodology: 12-Minute MicroSurvey
Crowds: PCPs, Oncologists, & Pediatricians
Sample Size: n=250
Fielding Period:
September 8-10, 2019

This report explores physician awareness of the following RNA- or DNA-based therapeutic methods:

  • RNAi (RNA interference)
  • siRNA (short interfering RNAs)
  • ASO (antisense oligonucleotides)
  • mRNA (messenger ribonucleic acid)
  • AAV (adeno-associated virus)
  • CRISPR (clustered regularly interspaced short palindromic repeats)
  • TALENs (transcription activator-like effector nuclease)

Download the report now!

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

Why Diversity Matters to Patients

Why Diversity Matters to Patients

How does a diverse patient audience feel about representation among their own physicians? Is the diversity outlook improving among healthcare professionals? Find out in our latest report from the 2023 Pharma Market Research Conference. We examined: Satisfaction with...

read more
ASH 2022 Real-Time Round-Up

ASH 2022 Real-Time Round-Up

The 2022 Annual Meeting of the American Society of Hematology (ASH) took place in person from December 10th to the 13th. InCrowd wanted to learn from those Hematologists and Hematology-Oncologists who attended these two objectives: Explore which condition had the most...

read more